tradingkey.logo

10X Genomics Inc

TXG
12.640USD
-0.110-0.86%
Fechamento 10/06, 16:00ETCotações atrasadas em 15 min
1.57BValor de mercado
PerdaP/L TTM

10X Genomics Inc

12.640
-0.110-0.86%

Mais detalhes de 10X Genomics Inc Empresa

10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for analyzing biological systems. Its Chromium platform includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Chromium Single Cell Multiome ATAC + Gene Expression, Visium Spatial Gene Expression, and others.

Informações de 10X Genomics Inc

Código da empresaTXG
Nome da Empresa10X Genomics Inc
Data de listagemSep 12, 2019
CEOMr. Serge Wilson Saxonov, Ph.D.
Número de funcionários1306
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 12
Endereço6230 Stoneridge Mall Road
CidadePLEASANTON
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94588
Telefone19254017300
Sitehttps://www.10xgenomics.com/
Código da empresaTXG
Data de listagemSep 12, 2019
CEOMr. Serge Wilson Saxonov, Ph.D.

Executivos da empresa 10X Genomics Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.06M
-0.09%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
369.61K
+4.34%
Whitaker (Eric S)
Whitaker (Eric S)
Chief Legal Officer
Chief Legal Officer
202.20K
+29.09%
Mr. Sridhar (Sri) Kosaraju
Mr. Sridhar (Sri) Kosaraju
Independent Director
Independent Director
59.45K
+34.83%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
44.69K
-14.35%
Ms. Kimberly J. (Kim) Popovits
Ms. Kimberly J. (Kim) Popovits
Independent Director
Independent Director
28.62K
+115.82%
Dr. Shehnaaz Suliman, M.D.
Dr. Shehnaaz Suliman, M.D.
Independent Director
Independent Director
28.62K
+115.82%
Mr. Adam S. Taich
Mr. Adam S. Taich
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Alan V. Mateo
Mr. Alan V. Mateo
Independent Director
Independent Director
--
--
Dr. Sarah A. Teichmann
Dr. Sarah A. Teichmann
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.06M
-0.09%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
369.61K
+4.34%
Whitaker (Eric S)
Whitaker (Eric S)
Chief Legal Officer
Chief Legal Officer
202.20K
+29.09%
Mr. Sridhar (Sri) Kosaraju
Mr. Sridhar (Sri) Kosaraju
Independent Director
Independent Director
59.45K
+34.83%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
44.69K
-14.35%
Ms. Kimberly J. (Kim) Popovits
Ms. Kimberly J. (Kim) Popovits
Independent Director
Independent Director
28.62K
+115.82%

Detalhamento da receita

Moeda: USDAtualizado em: há 7 horas
Moeda: USDAtualizado em: há 7 horas
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Consumables
122.19M
70.66%
Products and services revenue
27.75M
16.05%
Instruments
14.50M
8.38%
Services
8.47M
4.90%
Por RegiãoUSD
Nome
Receita
Proporção
United States
103.49M
59.85%
Europe, the Middle East and Africa
34.73M
20.09%
China
23.17M
13.40%
Asia Pacific
8.85M
5.12%
Americas
2.67M
1.54%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Consumables
122.19M
70.66%
Products and services revenue
27.75M
16.05%
Instruments
14.50M
8.38%
Services
8.47M
4.90%

Distribuição de ações

Atualizado em: sáb, 16 de ago
Atualizado em: sáb, 16 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
ARK Investment Management LLC
12.14%
The Vanguard Group, Inc.
10.85%
Fidelity Management & Research Company LLC
6.68%
BlackRock Institutional Trust Company, N.A.
6.63%
Sumitomo Mitsui Trust Bank, Limited
5.26%
Outro
58.44%
Investidores
Investidores
Proporção
ARK Investment Management LLC
12.14%
The Vanguard Group, Inc.
10.85%
Fidelity Management & Research Company LLC
6.68%
BlackRock Institutional Trust Company, N.A.
6.63%
Sumitomo Mitsui Trust Bank, Limited
5.26%
Outro
58.44%
Tipos de investidores
Investidores
Proporção
Investment Advisor
53.51%
Investment Advisor/Hedge Fund
22.37%
Hedge Fund
14.10%
Bank and Trust
6.38%
Research Firm
4.97%
Venture Capital
2.31%
Individual Investor
1.85%
Pension Fund
0.63%
Family Office
0.51%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
662
119.53M
104.47%
-16.69M
2025Q2
669
120.42M
108.39%
-15.20M
2025Q1
687
115.67M
104.27%
-8.84M
2024Q4
689
107.08M
98.92%
-12.41M
2024Q3
682
106.90M
100.39%
-9.08M
2024Q2
691
105.36M
99.70%
-5.09M
2024Q1
762
106.36M
101.17%
-3.12M
2023Q4
817
100.80M
96.01%
-9.73M
2023Q3
835
96.86M
93.80%
-12.55M
2023Q2
857
94.98M
96.77%
-15.37M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
ARK Investment Management LLC
13.89M
12.14%
+1.05M
+8.15%
Jun 30, 2025
The Vanguard Group, Inc.
12.42M
10.85%
+1.32M
+11.92%
Jun 30, 2025
Fidelity Management & Research Company LLC
7.64M
6.68%
-930.78K
-10.85%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
7.58M
6.63%
+2.17M
+40.18%
Jun 30, 2025
Sumitomo Mitsui Trust Bank, Limited
6.02M
5.26%
+654.60K
+12.20%
Jun 30, 2025
AQR Capital Management, LLC
4.14M
3.62%
+2.93M
+241.28%
Jun 30, 2025
BofA Global Research (US)
2.91M
2.54%
+350.99K
+13.74%
Jun 30, 2025
Millennium Management LLC
2.88M
2.52%
-2.65M
-47.89%
Jun 30, 2025
Two Sigma Investments, LP
2.84M
2.48%
-329.64K
-10.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
2.65M
2.32%
+773.20K
+41.18%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: há 16 horas
Atualizado em: há 16 horas
Nome
Proporção
ARK Genomic Revolution ETF
4.36%
WisdomTree BioRevolution Fund
2.19%
Global X Genomics & Biotechnology ETF
1.7%
Janus Henderson Small Cap Growth Alpha ETF
1.61%
ARK Innovation ETF
1.38%
Harbor Long-Short Equity ETF
1.06%
Invesco NASDAQ Future Gen 200 ETF
0.59%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.51%
Principal U.S. Small-Cap ETF
0.22%
Vanguard US Quality Factor ETF
0.16%
Ver Mais
ARK Genomic Revolution ETF
Proporção4.36%
WisdomTree BioRevolution Fund
Proporção2.19%
Global X Genomics & Biotechnology ETF
Proporção1.7%
Janus Henderson Small Cap Growth Alpha ETF
Proporção1.61%
ARK Innovation ETF
Proporção1.38%
Harbor Long-Short Equity ETF
Proporção1.06%
Invesco NASDAQ Future Gen 200 ETF
Proporção0.59%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporção0.51%
Principal U.S. Small-Cap ETF
Proporção0.22%
Vanguard US Quality Factor ETF
Proporção0.16%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI